Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature

RATIONALE: Cisplatin monotherapy-induced cardiotoxicity is rare, and the prevalence remains unknown. It's extremely important to stop cisplatin when cardiotoxicity is considered. PATIENT CONCERNS: A 53-year-old woman developed cervical cancer. She was administered cisplatin (37 mg/m(2)/wk) for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yang, Sun, Bin, Zhao, Bin, Mei, Dan, Gu, Qing, Tian, Zhuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314747/
https://www.ncbi.nlm.nih.gov/pubmed/30593170
http://dx.doi.org/10.1097/MD.0000000000013807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314747/
https://www.ncbi.nlm.nih.gov/pubmed/30593170
http://dx.doi.org/10.1097/MD.0000000000013807

Ejemplares similares